Osteoarthritis

Predicting rapid progression in knee osteoarthritis: a novel and interpretable automated machine learning approach, with specific focus on young patients and early disease

Ann Rheum DisPublished Prognostic modelling study

Authors' conclusion

Our novel tool's transparency and reliability in predicting rapid knee OA progression distinguish it from conventional 'black-box' methods

Study context

Population
Patients with knee osteoarthritis (OA) in the OA Initiative: FNIH OA Biomarker Consortium (training and hold-out validation) and Pivotal Osteoarthritis Initiative MRI Analyses study (external validation)
Outcome
Rapid progression of knee OA (multiclass: pain and/or radiographic; and binary)
Follow-up
2 years
Methodological detailsautomated machine learning, hold-out validation, external validation, subgroup analyses by age, sex and ethnicity, Web-based applications developed to visualise personalised predictions
  • Automated machine learning
  • Hold-out validation
  • External validation
  • Subgroup analyses by age, sex and ethnicity
  • Web-based applications developed to visualise personalised predictions

Performance

As reported in the abstract

External validation performance of clinical-only models (AUC-PRC)

Multiclass predictions, AUC-PRC

0.727

95% CI 0.726 to 0.728

Binary predictions, AUC-PRC

0.764

95% CI 0.762 to 0.766

Further findings

Multiclass models in early-stage OA (subgroup), AUC-PRC

AUC-PRC range
0.724-0.806

Binary models in patients younger than 60 (subgroup), AUC-PRC

AUC-PRC range
0.617-0.693

Key predictors of progression

Patient-reported outcomes and MRI features emerged as key predictors; subgroup differences noted

Original publication

Predicting rapid progression in knee osteoarthritis: a novel and interpretable automated machine learning approach, with specific focus on young patients and early disease. Ann Rheum Dis. Published 2 January 2025. doi:10.1136/ard-2024-225872

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.